Michael S. Weiss
CEO at TG Therapeutics; Executive Vice Chairman at Fortress Biotech; Director at Mustang Bio. Based in Bay Harbor Islands, Florida.
- Rank
- 393rd of 14,644
- Companies held
- 2
- Largest holding
- TGTX, 99.4% of total
- Latest SEC filing
- Mar 18, 2026
- Listed but not counted
- $434
What the $638M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| TG Therapeutics TGTX Common Stock | Directly | 9,778,086 | $64.88 | $634M | 99.4% | Form 4, Jan 8, 2026 |
| Fortress Biotech FBIO common stock, par value $0.001 | Directly | 2,276,562 | $1.77 | $4.0M | 0.6% | Form 4, Mar 18, 2026 |
Share counts are the amounts Michael S. Weiss reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Michael S. Weiss's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Mustang Bio MBIO COMMON STOCK, PAR VALUE $0.0001 | Through Caribe BioAdvisors, LLC Held by an investment fund or partnership | 993 split-adjusted | $0.37 | $367 | — | Form 4, Jul 5, 2023 |
| Mustang Bio MBIO COMMON STOCK, PAR VALUE $0.0001 | Through Caribe BioAdvisors, LLC Held by an investment fund or partnership | 181 split-adjusted | $0.37 | $67 | — | Form 4, Jul 29, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 390 | Jonathan E. Lim Chairman & CEO, Erasca. South San Francisco, CA | $642M |
| 391 | June Ou Director, Figure Technology Solutions. Reno, NV | $642M |
| 392 | Jingye Chen CPO, Shopee, Sea | $640M |
| 393 | Michael S. Weiss CEO, TG Therapeutics. Bay Harbor Islands, FL | $638M |
| 394 | Paul J. Fribourg Director, International Flavors & Fragrances. New York, NY | $636M |
| 395 | Lawrence P. Oreilly Director, O'Reilly Automotive. Springfield, MO | $634M |
| 396 | Sebastian Siemiatkowski Chief Executive Officer, Klarna Group | $633M |
Other TG Therapeutics insiders
All TGTX insiders- Sean A. Power$51.8MCFO. #2483 overall
- Kenneth Hoberman$18.1MDirector. #4911 overall
- Yann Echelard$14.5MDirector. #6610 overall
- Daniel Hume$12.5MDirector. #7410 overall
- Laurence N. Charney$10.9MDirector. #8043 overall
- Sagar Lonial$6.1MDirector. #12612 overall
Questions
How much stock does Michael S. Weiss own?
Michael S. Weiss holds $638,431,734 in listed stock based on SEC filings and current prices, mostly TG Therapeutics (TGTX). That ranks 393rd on the Stock Rich List.
Is this Michael S. Weiss's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.